Geoffrey Dusheiko - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Geoffrey Dusheiko

Showing results (111-120 of 115) with videos related to

Pageof 12

Sort By:

You have reached the last page of results.This site can display upto 115 results.

The New England Journal of Medicine|June 24, 2011

Telaprevir for previously untreated chronic hepatitis C virus infectionIra M Jacobson, John G McHutchison, Geoffrey Dusheiko, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 11, 2012

The diversity and management of chronic hepatitis B virus infections in the United Kingdom: a wake-up callRichard S Tedder, Alison J Rodger, Lori Fries, et al.

Journal of Viral Hepatitis|May 27, 2024

Peer support for people living with hepatitis B virus-A foundation for treatment expansionLouise O Downs, Kenneth Kabagambe, Sarah Williams, et al.

The Lancet. Microbe|April 12, 2025

Hepatitis B virus resistance to nucleos(t)ide analogue therapy: WHO consultation on questions, challenges, and a roadmap for the fieldSheila F Lumley, Jolynne Mokaya, Tongai G Maponga, et al.

Lancet (London, England)|December 5, 2021

The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortalityTom H Karlsen, Nick Sheron, Shira Zelber-Sagi, et al.

Pageof 12

Search research articles

Showing results (111-120 of 115) with videos related to

Sort By:

Pageof 12

You have reached the last page of results.This site can display upto 115 results.

The New England Journal of Medicine|June 24, 2011

Telaprevir for previously untreated chronic hepatitis C virus infectionIra M Jacobson, John G McHutchison, Geoffrey Dusheiko, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 11, 2012

The diversity and management of chronic hepatitis B virus infections in the United Kingdom: a wake-up callRichard S Tedder, Alison J Rodger, Lori Fries, et al.

Journal of Viral Hepatitis|May 27, 2024

Peer support for people living with hepatitis B virus-A foundation for treatment expansionLouise O Downs, Kenneth Kabagambe, Sarah Williams, et al.

The Lancet. Microbe|April 12, 2025

Hepatitis B virus resistance to nucleos(t)ide analogue therapy: WHO consultation on questions, challenges, and a roadmap for the fieldSheila F Lumley, Jolynne Mokaya, Tongai G Maponga, et al.

Lancet (London, England)|December 5, 2021

The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortalityTom H Karlsen, Nick Sheron, Shira Zelber-Sagi, et al.

Pageof 12